66 results
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II)
29 Mar 2021
This is the first prospective natural history study to evaluate the utility of comprehensive intravascular imaging with both IVUS and NIRS in predicting future adverse events following acute myocardial infarction.
Reviewer
Reviewer
Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque
30 Nov 2020
Do you have any experience with NIRS technology? Do you think that use of 3rd generation DES would have shown better results than BVS? Read this review by S. Brugaletta
Reviewer
The EURO SHOCK Trial: Design, aims and objectives
19 Nov 2020
Randomised comparison of extra corporeal membrane oxygenation (ECMO) delivered after acute-PCI plus standard of care versus standard of care alone after acute PCI, in patients presenting with ACS and cardiogenic shock
Reviewer
Association of intra-arrest transport vs continued on-scene resuscitation with survival to hospital discharge among patients with out-of-hospital cardiac arrest (OHCA)
04 Nov 2020
This multicentre time-dependent propensity score–matched cohort study was designed to evaluate the impact of intra-arrest transport as compared to continued on-scene resuscitationon survival to hospital discharge among patients experiencing out-of-hospital cardiac arrest.
Reviewer
Reviewer
Arterial lactate in cardiogenic shock: Prognostic value of clearance versus single values
15 Oct 2020
This subanalysis of the IABP-SHOCK study shows how a negative trial, when properly conducted, can generate useful hypothesis-generating information with relevant clinical impact. Find out more!
Reviewer
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome
06 Oct 2020
Reviewer
MIRTOS trial: Ticagrelor versus Clopidogrel in patients with STEMI treated with thrombolysis
07 Aug 2020
The MIRTOS trial, which included STEMI patients receiving DAPT and thrombolysis ‘together’, aimed to evaluate whether ticagrelor could improve microvascular perfusion and reduce MACE compared to clopidogrel
Reviewer
Reviewer
Cangrelor, Tirofiban and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial
15 Jul 2020
The results of the FABOLUS FASTER trial clearly highlight that a high residual platelet reactivity persists when targeting platelet activation by inhibition of the P2Y12 receptor either with Prasugrel or Cangrelor, while tackling the mechanism of platelet adhesion thought the inhibition of GPIIB/IIIA might almost completely...
Reviewer
Multivessel versus culprit-only revascularisation in STEMI and multivessel coronary artery disease: meta-analysis of randomised trials
23 Jul 2020
The current meta-analysis study sought to evaluate contemporary randomized trials on multivessel versus IRA-only PCI in patients presenting with STEMI and multivessel CAD.
Reviewer
Subcutaneous selatogrel inhibits platelet aggregation in patients with acute myocardial infarction
07 Jul 2020
This study sought to assess the antiplatelet response to selatogrel, a novel subcutaneous reversible P2Y12 receptor antagonist, in patients with AMI.
Reviewer
Reviewer
